20086 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Excipients; Inactive ingredients; Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
Pharmaceutical compositions of pimobendan
#602ANTIMICROBIAL COMPOSITIONS AND METHODS FOR PREVENTING INFECTION IN SURGICAL INCISION SITES
#603Pharmaceutical formulation containing gelling agent
#604Formulations of rifaximin and uses thereof
#605Controlled release formulations for the induction and proliferation of blood cells
#606Method for the production of emulsion-based microparticles
#607Abuse resistant forms of immediate release oxymorphone, method of use and method of making
#608Abuse resistant forms of extended release hydrocodone, method of use and method of making
#609Bendamustine pharmaceutical compositions
#610Abuse resistant forms of extended release oxymorphone, method of use and method of making
#611Abuse resistant forms of immediate release hydromorphone, method of use and method of making
#612Reversible, on-demand generation of aqueous two-phase microdroplets
#613Sustained delivery of therapeutic agents to an eye compartment
#614Tamper resistant dosage forms
#615Tamper resistant dosage forms
#616Tamper resistant dosage forms
#617Self-assembled toroidal-spiral particles and manufacture and uses thereof
#618Tamper resistant dosage forms
#619Corticosteroids for the treatment of joint pain
#620Biocompatible particles and method for preparing same
#621Methods for treating edema in the eye and intraocular implants for use therefor
#622Tamper-resistant pharmaceutical compositions of opioids and other drugs
#623Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
#624Composition for controlled release of physiologically active substance
#625Abuse resistant forms of extended release morphine, method of use and method of making
#62617-hydroxyprogesterone ester containing oral compositions and related methods
#627Pharmaceutical compositions of fenofibrate
#628Corticosteroids for the treatment of joint pain
#629Methods for Preparing Injectable Protein Microparticle Suspensions
#630TAMPER RESISTANT PHARMACEUTICAL FORMULATIONS
#631Water-soluble meloxicam granules
#632Particles comprising a releasable dopant therein
#633PHARMACEUTICAL COMPOSITIONS OF LIPASE-CONTAINING PRODUCTS, IN PARTICULAR OF PANCREATIN
#634Method of preparing microspheres by using polymer having sol-gel transition property and microspheres prepared thereby
#635Stealth polymeric particles for delivery of bioactive or diagnostic agents
#63617-hydroxyprogesterone ester containing oral compositions and related methods
#637Compositions including encapsulated isotretinoin and methods for use thereof
#638Polymeric depots for localization of agent to biological sites
#639Abuse resistant forms of extended release morphine, method of use and method of making
#640Abuse resistant forms of extended release morphine, method of use and method of making
#641Spray drying vancomycin
#642Method for treating intestinal fibrosis
#643Formulation for preventing or reducing bleeding at a surgical site
#644PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VII ENCAPSULATED IN MICELLES
#645Highly Bioavailable Composition Containing Eprosartan - Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer Complex
#646Pharmaceutical composition with improved bioavailability
#647Bioresorbable microparticles
#648System and method for multiphasic release of growth factors
#649Solid pharmaceutical and vaccine dose
#650Controlled agglomeration
#651Modified release compositions comprising tacrolimus
#652Modified release compositions comprising tacrolimus
#653Injectable microspheres for dermal augmentation and tissue bulking
#654Modified release compositions comprising tacrolimus
#655Fulvestrant nanosphere/microsphere and preparative method and use thereof
#656Tamper resistant dosage forms
#657Implantable bio-resorbable polymer charged with fragile macromolecules
#658Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
#659Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug
#660Kit for multifunctional compounds forming crosslinked biomaterials
#661Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
#662Method for reducing transplant rejection in the eye and intraocular implants for use therefor
#663Drug-delivery systems
#664Tamper resistant dosage forms
#665Tamper resistant dosage forms
#666Tamper resistant dosage forms
#667Tamper resistant dosage forms
#668Tamper resistant dosage forms
#669Tamper resistant dosage forms
#670Pharmaceutical formulation containing gelling agent
#671Controlled release antimicrobial compositions and methods for the treatment of otic disorders
#672Process for producing drug-block copolymer composite and pharmaceutical preparation containing same
#673Combination of active loaded granules with additional actives
#674Water-soluble meloxicam granules
#675Dosage formulation
#676Aildenafil citrate crystal form O, preparation method and use thereof
#677Composition comprising tetracyclic compound
#678Use of polyether-based and vinyl monomer-based copolymers as binders for dosing forms comprising solid active ingredients
#679DOSAGE FORM, AND METHODS OF MAKING AND USING THE SAME, TO PRODUCE IMMUNIZATION IN ANIMALS AND HUMANS
#680Methods and compositions for gene therapy and GHRH therapy
#681Electrostatically bonded vesicle
#682PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#683Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
#684HOT-MELT EXTRUDED COMPOSITIONS CONTAINING PLANT-DERIVED PHENOLIC MATERIALS AND PROCESSES FOR THE PREPARATION THEREOF
#685Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative
#686Long circulating nanoparticles for sustained release of therapeutic agents
#687Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
#68817-hydroxyprogesterone ester-containing oral compositions and related methods
#689Pharmaceutical compositions comprising nilotinib or its salt
#690Methods and compositions for bone formation
#691Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
#692Spray drying vancomycin
#693Pharmaceutical compositions for parenteral administration
#694Swellable particles for drug delivery
#695MICROPARTICLE DISPERSION LIQUID MANUFACTURING METHOD AND MICROPARTICLE DISPERSION LIQUID MANUFACTURING APPARATUS
#696Sustained delivery of therapeutic agents to an eye compartment
#697Capsule of compound danshen dripping pills
#698Biocompatible and biodegradable elastomeric polymers
#699ORAL DOSAGE FORM
#700Corticosteroids for the treatment of joint pain
#701Biodegradable PAOX polymer particle with cationic property
#702TRANSDERMAL DELIVERY OF METFORMIN
#703CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN
#704Cellulose capsules and methods for making them
#705MELT-GRANULATED CINACALCET
#706NOVEL FORMULATION OF METAXALONE
#707Methods of treating proliferative diseases
#708Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same
#709PREPARATION OF POLYPHOSPHAZENE MICROSPHERES
#710Hydrogel encapsulated cells and anti-inflammatory drugs
#711Compositions controlling pH range of release and/or release rate
#712HOT-MELT EXTRUDED COMPOSITIONS CONTAINING PLANT-DERIVED PHENOLIC MATERIALS AND PROCESSES FOR THE PREPARATION THEREOF
#713STABILIZATION OF AMORPHOUS DRUGS USING SPONGE-LIKE CARRIER MATRICES
#714Method, composition and package for bowel cleansing
#715Method of making solid dispersions of highly crystalline therapeutic compounds
#716Pellets coated with coatings containing active substances
#717Drug delivery system comprising polyoxazoline and a bioactive agent
#718Abuse resistant oral opioid formulations
#719Abuse resistant forms of immediate release oxycodone, method of use and method of making
#720CONTROLLABLE RELEASE COMPOSITION AND METHOD FOR PREPARING SAME
#721Prasugrel in non-crystalline form and pharmaceutical composition thereof
#722Process For Producing Pellets Comprising At Least One Water-Soluble Component
#723NANODISPERSIONS
#724NANODISPERSIONS
#725Stealth polymeric particles for delivery of bioactive or diagnostic agents
#726Compositions and methods for delivery of frozen particle adhesives
#727Sustained-release composition containing tetrahydropyrido[4,3-b]indole derivatives and preparation of the derivatives
#728COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION
#729Sustained-release drug carrier composition
#730PHARMACEUTICAL COMPOSITION FOR TREATING HCV INFECTIONS
#731Compositions and methods for biological remodeling with frozen particle compositions
#732Pharmaceutical formulation containing gelling agent
#733Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
#734Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
#735Particles for Inhalation Having Sustained Release Properties
#736Compositions and methods for biological remodeling with frozen particle compositions
#737DOSAGE FORMS OF APIXABAN
#738Methods for processing microspheres
#739QUICK DISSOLVE COMPOSITIONS AND TABLETS BASED THEREON
#740FORMULATIONS OF RIFAXIMIN AND USES THEREOF
#741Synthesis of stable elastomeric negative acoustic contrast particles
#742Stable elastomeric negative acoustic contrast particles and their use in acoustic radiation fields
#743METHODS FOR REDUCING OR PREVENTING TRANSPLANT REJECTION IN THE EYE AND INTRAOCULAR IMPLANTS FOR USE THEREFOR
#744Branched Polyesters Based On Citric Acid, Their Preparation And Use
#745SOLID RETIGABINE IN NON-CRYSTALLINE FORM
#746POROUS STRUCTURES WITH MODIFIED BIODEGRADATION KINETICS
#747Method for treating hyperglycemia
#748Photo-Crosslinked Nucleic Acid Hydrogels
#749Tacrolimus for improved treatment of transplant patients
#750PHARMACEUTICAL COMPOSITIONS FOR GASTROINTESTINAL DRUG DELIVERY
#751Process for Producing Rapidly Disintegrating Spheroids (Pellets), Granules and/or Mixtures Thereof
#752AMORPHOUS AMBRISENTAN
#753Method for producing preparations of substances poorly soluble in water
#754METHODS FOR REDUCING OR NEOVASCULARIZATION OR EDEMA
#755MICROSPHERES FOR THE SUSTAINED RELEASE OF OCTREOTIDE WITH A LOW INITIAL BURST
#756COMPACTED CINACALCET
#757Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
#758Fulvestrant nanosphere/microsphere and preparative method and use thereof
#759Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
#760SOLID COMPOSITION CONTAINING THE INGREDIENT RASAGILINE
#761Solid dispersions containing kinase inhibitors
#762Controlled release micro-capsule for osteogenic action
#763Biodegradable Polymer Encapsulated Microsphere Particulate Film and Method of Making Thereof
#764Microparticle dispersion liquid manufacturing method and microparticle dispersion liquid manufacturing apparatus
#765Tacrolimus For Improved Treatment Of Transplant Patients
#766Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
#767Lung targeting dual drug delivery system
#768Solid dispersions comprising tacrolimus
#769Modified release compositions comprising tacrolimus
#770Modified release compositions comprising tacrolimus
#771Modified release compositions comprising tacrolimus
#772Modified release compositions comprising tacrolimus
#773Methods and Compositions for Stabilization of a Virus Vaccine
#774Sustained-release donepezil formulation
#775Methods and compositions for treating pain comprising a statin
#776Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents
#777Naltrexone Long Acting Formulations and Methods of Use
#778Pharmaceutical preparation containing gabapentin
#779Pharmaceutical compositions configured to deter dosage form splitting
#780Use Of Polyether-Based And Vinyl Monomer-Based Copolymers As Binders For Dosing Forms Comprising Solid Active Ingredients
#781Nano-, Micro-, Macro- Encapsulation And Release Of Materials
#782Absorption of therapeutic agents across mucosal membranes or the skin
#783PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(E-CAPROLACTONE)
#784Methods and compositions related to clot-binding compounds
#785Abuse resistant drugs, method of use and method of making
#786Abuse resistant forms of extended release morphine, method of use and method of making
#787Abuse resistant forms of extended release morphine with oxycodone, method of use and method of making
#788Abuse resistant forms of extended release hydrocodone, method of use and method of making
#789Abuse resistant forms of extended release oxymorphone, method of use and method of making
#790Abuse resistant forms of extended release oxycodone, method of use, and method of making
#791Abuse resistant forms of extended release hydromorphone, method of use and method of making
#792Amphiphilic polymer functionalized by methionine
#793Frozen compositions and methods for piercing a substrate
#794Pharmaceutical Compositions of Amorphous Atorvasta and Process for Preparing Same
#795Pharmaceutical Compositions
#796Tamper-resistant pharmaceutical compositions of opioids and other drugs
#797GRANULATION OF ACTIVE PHARMACEUTICAL INGREDIENTS
#798SINGLE DOSAGE PHARMACEUTICAL FORMULATION COMPRISING EPROSARTAN MESYLATE
#799Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
#800Method of producing polymeric particles with selected size, shape, morphology and composition
#801PROCESS FOR PREPARING ORALLY ADMINISTERED DABIGATRAN FORMULATIONS
#802Oral compositions of clindamycin
#803ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#804Nanocarrier and nanogel compositions
#805TABLET COMPRISING EPROSARTAN MESYLATE
#806FORMULATION FOR PREVENTING OR REDUCING BLEEDING AT A SURGICAL SITE
#807Residual solvent extraction method and microparticles produced thereby
#808POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTSMETHODS FOR
#809Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet
#810Abuse resistant drugs, method of use and method of making
#811ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#812NOVEL DOSAGE FORMULATION
#813ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#814Pharmaceutical compositions comprising phosphate-binding polymer
#815Nanoparticles for delivery of active agents
#816Nanoparticles for delivery of active agents
#817SOLID DOSAGE FORMS OF HIV PROTEASE INHIBITORS
#818Hydrogels with covalent and noncovalent crosslinks
#819Injectable microspheres for dermal augmentation and tissue bulking
#820Immediate release pharmaceutical granule compositions and a continuous process for making them
#821Preparation method for solid dispersions
#822Preparation of polyphosphazene microspheres
#823Immediate release pharmaceutical granule compositions and a continuous process for making them
#824Abuse resistant oral opioid formulations
#825Drug delivery compositions including nanoshells for triggered drug release
#826Respiratory dispersion for metered dose inhalers comprising perforated microstructures
#827Cell-mediated delivery and targeted erosion of noncovalently crosslinked hydrogels
#828Injectable hydrogel microspheres from aqueous two-phase system
#829Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
#830Dispersion of poloxamer-protein particles, methods of manufacturing and uses thereof
#831DRY POWDER MICROPARTICLES FOR PULMONARY DELIVERY
#832PHARMACEUTICAL COMPOSITION COMPRISING DESLORATADINE
#833PREPARATION OF INJECTABLE SUSPENSIONS HAVING IMPROVED INJECTABILITY
#834Multifunctional and biologically active matrices from multicomponent polymeric solutions
#835ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#836MICROPARTICLE COMPRISING CROSS-LINKED POLYMER
#837PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN
#838PROCESS FOR FORMING SOLID ORAL DOSAGE FORMS OF ANGIOTENSIN II RECEPTOR ANTAGONISTS
#839Pulmonary delivery particles comprising an active agent
#840Condom with Localized Active Agent
#841Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
#842Controlled Release Devices and Methods for Delivery of Nucleic Acids
#843Particles for delivery of nucleic acids and related devices and methods
#844Polypeptides, antibody variable domains and antagonists methods for
#845Pharmaceutical compositions of fenofibrate
#846POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS
#847METHODS FOR SELECTING PROTEASE RESISTANT POLYPEPTIDES
#848Anti-angiogenic nanoparticle compositions
#849MICROPARTICLES COMPRISING A CROSSLINKED POLYMER
#850Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents
#851Polyarylates for drug delivery and tissue engineering
#852Methods for preparing polymer microparticles
#853SUSTAINED-RELEASE NANOPARTICLE COMPOSITIONS AND METHODS USING THE SAME
#854Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine
#855Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine
#856Systems, devices, and methods for making or administering frozen particles
#857Systems, devices, and methods for making or administering frozen particles
#858PROCESS FOR PREPARING PARTICLES OF OPIOIDS AND COMPOSITIONS PRODUCED THEREBY
#859QUICK DISSOLVE COMPOSITIONS AND TABLETS BASED THEREON
#860PROCESS FOR PREPARING MICROPARTICLES THROUGH PHASE INVERSION PHENOMENA
#861HOT-MELT MICROPELLETS
#862Systems, devices, and methods for making or administering frozen particles
#863Pharmaceutical formulation containing gelling agent
#864Systems, devices, and methods for making or administering frozen particles
#865Systems, devices and methods for making or administering frozen particles
#866Frozen compositions and methods for piercing a substrate
#867Frozen compositions and methods for piercing a substrate
#868Formulations of single domain antigen binding molecules
#869Frozen compositions and methods for piercing a substrate
#870PHARMACEUTICAL COMPOSITION COMPRISING A HOT-MELT GRANULATED LUBRICANT
#871Solid Pharmaceutical And Vaccine Dose
#872Frozen compositions and array devices thereof
#873Compositions and methods for biological remodeling with frozen particle compositions
#874Frozen compositions and methods for piercing a substrate
#875Compositions and methods for delivery of frozen particle adhesives
#876Compositions and methods for delivery of frozen particle adhesives
#877Compositions and methods for therapeutic delivery with frozen particles
#878Compositions and methods for biological remodeling with frozen particle compositions
#879Compositions and methods for biological remodeling with frozen particle compositions
#880Multifunctional and biologically active matrices from multicomponent polymeric solutions
#881Compositions and methods for surface abrasion with frozen particles
#882Frozen piercing implements and methods for piercing a substrate
#883Frozen compositions and methods for piercing a substrate
#884Compositions and methods for administering compartmentalized frozen particles
#885Compositions and methods for administering compartmentalized frozen particles
#886Compositions and methods for delivery of frozen particle adhesives
#887Compositions and methods for therapeutic delivery with frozen particles
#888Compositions and methods for therapeutic delivery with frozen particles
#889Compositions and methods for therapeutic delivery with frozen particles
#890Compositions and methods for therapeutic delivery with frozen particles
#891Compositions and methods for surface abrasion with frozen particles
#892Compositions and methods for biological remodeling with frozen particle compositions
#893Compositions and methods for therapeutic delivery with frozen particles
#894Compositions and methods for therapeutic delivery with frozen particles
#895Compositions and methods for therapeutic delivery with frozen particles
#896Compositions and methods for surface abrasion with frozen particles
#897Tacrolimus for improved treatment of transplant patients
#898Highly Bioavailable Composition Containing Eprosartan-Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer Complex
#899Pharmaceutical compositions comprising nilotinib hydrochloride monohydrate
#900MICROSPHERES FOR THE SUSTAINED RELEASE OF OCTREOTIDE WITH A LOW INITIAL BURST